Skip to Content
You are currently on the new version of our website. Access the old version .

Human Cancer Immunotherapy with Antibodies to the PD-1 and PD-L1 Pathway

This special issue belongs to the section "Immunology & Rheumatology".

Special Issue Information

Keywords

  • tumor immunotherapy
  • check point inhibitors
  • programmed cell death protein 1
  • programmed cell death 1 ligand 1
  • biomarker
  • immune monitoring
  • T cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Published Papers

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383